Atherosclerosis and cognitive impairment are linked in the elderly. The Leiden 85-plus Study

Atherosclerosis

Volumn 165, Issue 2, 2002, Pages 353-359

  Van Exel, E ^a   Gussekloo, J ^a   Houx, P ^b   De Craen, A J M ^a   Macfarlane, P W ^c   Bootsma van der Wiel, A ^a   Blauw, G J ^a   Westendorp, R G J ^a  

^a Dept of Gen Int Med ^*  (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cognitive impairment; Elderly; Ischemic disease in the brain; Late onset dementia; Systolic hypertension; Vascular lesions

Indexed keywords

AGED; ARTICLE; ATHEROSCLEROSIS; BODY BURDEN; CARDIOVASCULAR SYSTEM; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; DATA ANALYSIS; DEMENTIA; DOSE RESPONSE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROPHYSIOLOGY; PATHOLOGY; POPULATION; PRIORITY JOURNAL; PROPHYLAXIS; RATING SCALE; SPEECH; STATISTICAL SIGNIFICANCE; VELOCITY; ARTERIOSCLEROSIS; EPIDEMIOLOGY; HEALTH SURVEY; NETHERLANDS; NEUROPSYCHOLOGICAL TEST; RISK; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; COGNITION DISORDERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEMENTIA; FEMALE; HUMANS; MALE; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; POPULATION SURVEILLANCE; SEX FACTORS;

EID: 0036890085     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00253-8     Document Type: Article

References (38)

1. Desmond D.W., Moroney J.T., Paik M.C., et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology. 54:2000;1124-1131.
2. Heyman A., Fillenbaum G.G., Welsh-Bohmer K.A., et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology. 51:1998;159-162.
3. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease: The Nun study. J. Am. Med. Assoc. 277:1997;813-817.
4. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community based population in England and Wales. Lancet 2001;357:169-75.
5. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging. 21:2000;321-330.
6. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 352:1998;1347-1351.
7. van Exel E., Gussekloo J., de Craen A.J.M., et al. Cognitive function in the oldest old: Women perform better than men. J. Neurol. Neurosurg. Psychiatry. 71:2001;29-32.
8. Schmand B., Smit J.H., Geerlings M.I., et al. The effects of intelligence and education on the development of dementia. A test of the brain reserve hypothesis. Psychol. Med. 27:1997;1337-1344.
9. Orencia A., Bailey K., Yawn B.P., Kottke T.E. Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death. J. Am. Med. Assoc. 269:1993;2392-2397.
10. Mittelmark M.B., Psaty B.M., Rautaharju P.M., et al. Prevalence of cardiovascular pathologies among older adults. The cardiovascular health study. Am. J. Epidemiol. 137:1993;311-317.
11. Hofman A., Ott A., Breteler M.M.B., et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 349:1997;151-154.
12. Breteler M.M.B., Claus J.J., Grobbee D.E., Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. Br. Med. J. 308:1994;1604-1608.
13. Cerhan J.R., Folsom A.R., Mortimer J.A., et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology. 44:1998;95-105.
14. Auperin A., Berr C., Bonithon-Kopp C., et al. Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke. 27:1996;1290-1295.
15. Tombaugh T.N., McIntyre N.J. The Mini-Mental State Examination: A comprehensive review. J. Am. Geriatrics Soc. 40:1992;922-935.
16. Heeren T.J., Lagaay A.M., von Beek W.C., Rooymans H.G., Hijmans W. Reference values for the Mini-Mental State Examination (MMSE) in octo- and nonagenarians. J. Am. Geriatr. Soc. 38:1990;1093-1096.
17. Møller J.T., Cluitmans P., Rasmussenm L.S., et al. Long-term postoperative cognitive dysfunction in the elderly; ISPOCD1 study. Lancet. 351:1998;857-861.
18. Lezak M.D. Neuro-psychological assessment. 3rd ed. 1995;Oxford University Press, New York.
19. Macfarlane P.W., Latif S. Automated Serial ECG Comparison based on the Minnesota code. J. Electrocardiol. 29(S):1996;29-34.
20. Simons P.C.G., Algra A., Bots M.L., Grobbee D.E., van der Graaf Y. Common carotid intima-media thickness and arterial stiffness. Indicators of cardiovascular high-risk patients. The SMART study (Second Manifestations of ARTerial disease). Circulation. 100:1999;951-957.
21. Rautaharju P. Electrocardiography in epidemiology and clinical trials. Macfarlane P.W., Lawrie T.D.V., Comprehensive electrocardiology. 1989;1219-1266 Pergamon Press, Oxford.
22. Yesavage J.A., Brink T.L., Rose T.L., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 1:1982;37-49.
23. Burke W.J., Houston M.J., Boust S.J., Roccaforte W.H. Use of the Geriatric Depression Scale in dementia of the Alzheimer type. J. Am. Geriatr. Soc. 37:1989;856-860.
24. Moore A.R., O'Keeffe S.T. Drug-induced cognitive impairment in the elderly. Drugs Aging. 15:1999;15-28.
25. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer's disease. Exp. Gerontol. 33:1998;371-378.
26. Campbell M.J., Gardner M.J. Calculating confidence intervals for some non-parametric analyses. Gardner M.J., Altman D.G., Statistics with confidence. 1989;71-79 British Medical Journal, London.
27. Hollander M., Wolfe D.A. A distribution free test for ordered alternatives (Jonckheere, Terpstra). Hollander M., Wolfe D.A., Nonparametric statistical methods. 1999;202-212 John Wiley and Sons, New York.
28. Jorm A.F., Jolley D. The incidence of dementia. A meta-analysis. Neurology. 51:1998;728-733.
29. Breteler M.M., van Swieten J.C., Bots M.L., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 44:1994;1246-1252.
30. de Leeuw F.E., De Groot J.C., Oudkerk M., et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke. 31:2000;425-429.
31. de Groot J.C., de Leeuw F.E., Oudkerk M., et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann. Neurol. 47:2000;145-151.
32. Gussekloo J., Heeren T.J., Izaks G.J., Ligthart G.J., Rooijmans H.G. A community based study of the incidence of dementia in subjects aged 85 years and over. J. Neurol. Neurosurg. Psychiatry. 59:1995;507-510.
33. Kannel W.B., Wolf P.A., Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. J. Am. Med. Assoc. 250:1983;2942-2946.
34. Cattell R.B. Theory of fluid and crystallized intelligence: A critical experiment. J. Educational Psychol. 54:1963;1-22.
35. Birren J.E., Schaie K.W. Handbook of the psychology of aging. 1985;Van Nostrand Reinhold, New York.
36. Salthouse T.A. Resource reduction interpretation of cognitive aging. Dev. Rev. 8:1988;238-272.
37. Blauw G.J., Lagaay A.M., Smelt A.H., Westendorp R.G.J. Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke. 28:1997;946-950.
38. Staessen J.A., Gasowski J., Wang J.G., et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 355:2000;865-872.